3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Gemcitabine
7
Cystectomy
5
Cisplatin
5
durvalumab
4
Neoadjuvant Therapy
4
Mitomycin
4
atezolizumab
3
Transurethral Resection of Bladder
3
Nivolumab
3
Epirubicin
3
Chemoradiotherapy
3
BCG Vaccine
3
Anesthesia, Spinal
3
tislelizumab
2
disitamab vedotin
2
catumaxomab
2
Vitamin E
2
Urinary Diversion
2
Sunitinib
2
Selenium
2
Robotic Surgical Procedures
2
Multiparametric Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Immunohistochemistry
2
Fentanyl
2
Docetaxel
2
Diathermy
2
Cystoscopy
2
Chemoprevention
2
BCG Connaught
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Urinary Bladder Neoplasms
×
bintrafusp alfa protein, human
×
Clear all
NCT04878250
2021-05-07
PEBBLE
Queen Mary University of London
Phase 2
Unknown
49 enrolled